Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

AXT107 an Inhibitor of Neovascularization, Vascular Leakage, and Inflammation, Is Well-Tolerated and Could Potentially Be Dosed Once a Year to Treat Retinal Vascular Diseases

Niranjan Pandey

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3304. doi:

ARVO Annual Meeting Abstract July 2019

AXT107, a Peptide that Disrupts Integrins, Suppresses Vascular Leakage in the Setting of Ocular Inflammation

Raquel Formica; Sean Hackett; Zibran Hafiz; Adam Mirando; Jordan J Green; Aleksander S Popel; Niranjan B Pandey; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4073. doi:

Retina October 2018

Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection

PDF

Yu Zhang; Hojjat Bazzazi; Raquel Lima e Silva; Niranjan B. Pandey; Jordan J. Green; Peter A. Campochiaro; Aleksander S. Popel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(12):5266-5276. doi: https://doi.org/10.1167/iovs.17-23632

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

A small biomimetic collagen IV derived peptide reduces leakage and suppresses ocular neovascularization in mouse models

Raquel Formica; Valeria E Lorenc; Niranjan B Pandey; Ji-kui Shen; Jayoung Kim; Aleksander S Popel; Jordan Green; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3269. doi:

ARVO Annual Meeting Abstract June 2017

Biodegradable polymeric microparticles allow sustained durability of a multimodal anti-angiogenic peptide to treat neovascular age-related macular degeneration

Jayoung Kim; Raquel Formica; Ron Shmueli; Adam Mirando; Niranjan B Pandey; Aleksander S Popel; Peter A Campochiaro; Jordan J Green

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1949. doi:

Advertisement